This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Hepatalgia is a term used to describe pain or discomfort in the upper abdomen that is caused by inflammation or other diseases of the liver. It is sometimes referred to as liver pain, or hepatic pain. It usually occurs in the right upper quadrant of the abdomen, where the liver is located. It can range from mild to severe in intensity, and may be accompanied by other symptoms such as fever, nausea, vomiting, fatigue, and jaundice. The most common cause of hepatalgia is hepatitis, an inflammation of the liver caused by a virus. Other causes include cirrhosis of the liver, cancer, fatty liver, alcohol use, and drug use. In some cases, hepatalgia can be caused by gallstones, kidney stones, or other metabolic disorders. Diagnosis of hepatalgia is based on the patient’s symptoms and physical examination. Blood tests can help to diagnose the underlying cause of the pain. Imaging tests such as ultrasound, CT scan, and MRI may also be used to evaluate the liver for any abnormalities. Treatment for hepatalgia will depend on the underlying cause. If the pain is caused by a virus, medications such as antivirals may be prescribed to reduce the inflammation. If the pain is caused by a metabolic disorder, medications or dietary changes may be recommended. If the pain is caused by cancer, chemotherapy or radiation may be used. In most cases, hepatalgia can be managed with pain medications and lifestyle changes. It is important to maintain a healthy lifestyle and to follow the doctor’s instructions for treating the underlying condition. If the pain does not improve or is severe, it is important to seek medical attention right away.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States